ELLA C. MORGAN, JASMIN M. ALVES, TING CHOW, ANNY XIANG, KATHLEEN A. PAGE
{"title":"2078-LB: Prenatal Exposure to Maternal Obesity or Gestational Diabetes Is Associated with Gut Hormone Dysregulation in Children","authors":"ELLA C. MORGAN, JASMIN M. ALVES, TING CHOW, ANNY XIANG, KATHLEEN A. PAGE","doi":"10.2337/db25-2078-lb","DOIUrl":null,"url":null,"abstract":"Introduction and Objective: Children of mothers with obesity or gestational diabetes mellitus (GDM) face increased metabolic risk, yet mechanisms remain unclear. The gut hormones, GLP-1 and ghrelin, regulate appetite and glucose metabolism. GLP-1 enhances insulin secretion and satiety, while ghrelin stimulates hunger. We investigated whether exposure to maternal obesity or GDM is associated with alterations in GLP-1 and ghrelin responses to oral glucose. Methods: The analysis included 19 children (68% female; 12 GDM-exposed, 7 unexposed) aged 7-14 years from the BrainChild Study. Maternal pre-pregnancy BMI and GDM status were extracted from electronic medical records. Stored plasma samples were assayed for gut hormones collected after a 12-hour fast and 30-min post-oral glucose load (1.75 g/kg body weight). A multiplex immunoassay (MilliporeSigma) quantified active ghrelin and GLP-1. Spearman correlations assessed associations between maternal pre-pregnancy BMI and child hormone levels, and independent t-tests compared hormone responses between GDM-exposed and unexposed children, before and after adjusting for child age and sex. Results: Compared to unexposed children, GDM-exposed children had smaller post-glucose increases in GLP-1 levels (unadjusted: 29.07 vs. 17.87 pg/ml, p=0.17; adjusted: 29.13 vs. 17.95 pg/ml p=0.20) and less ghrelin suppression (unadjusted: -99.68 vs. -34.49 pg/ml, p=0.05; adjusted: -101.31 vs -43.19 pg/ml, p=0.08), respectively. Maternal pre-pregnancy BMI correlated with lower child GLP-1 secretion (unadjusted: ρ =-0.30, p=0.21; adjusted: ρ =-0.25, p=0.33) and less ghrelin suppression (unadjusted: ρ =0.55, p=0.01; adjusted: ρ =0.52, p=0.03). Conclusion: These preliminary findings suggest that prenatal exposure to maternal GDM or obesity is associated with altered GLP-1 and ghrelin responses to oral glucose. Further research is needed to elucidate how these changes contribute to metabolic risk in children. Disclosure E.C. Morgan: None. J.M. Alves: None. T. Chow: None. A. Xiang: None. K.A. Page: None. Funding American Diabetes Association (1-14-ACE-36); NIH (RO1DK134079), (RO1DK116858)","PeriodicalId":11376,"journal":{"name":"Diabetes","volume":"225 1","pages":""},"PeriodicalIF":6.2000,"publicationDate":"2025-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetes","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2337/db25-2078-lb","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and Objective: Children of mothers with obesity or gestational diabetes mellitus (GDM) face increased metabolic risk, yet mechanisms remain unclear. The gut hormones, GLP-1 and ghrelin, regulate appetite and glucose metabolism. GLP-1 enhances insulin secretion and satiety, while ghrelin stimulates hunger. We investigated whether exposure to maternal obesity or GDM is associated with alterations in GLP-1 and ghrelin responses to oral glucose. Methods: The analysis included 19 children (68% female; 12 GDM-exposed, 7 unexposed) aged 7-14 years from the BrainChild Study. Maternal pre-pregnancy BMI and GDM status were extracted from electronic medical records. Stored plasma samples were assayed for gut hormones collected after a 12-hour fast and 30-min post-oral glucose load (1.75 g/kg body weight). A multiplex immunoassay (MilliporeSigma) quantified active ghrelin and GLP-1. Spearman correlations assessed associations between maternal pre-pregnancy BMI and child hormone levels, and independent t-tests compared hormone responses between GDM-exposed and unexposed children, before and after adjusting for child age and sex. Results: Compared to unexposed children, GDM-exposed children had smaller post-glucose increases in GLP-1 levels (unadjusted: 29.07 vs. 17.87 pg/ml, p=0.17; adjusted: 29.13 vs. 17.95 pg/ml p=0.20) and less ghrelin suppression (unadjusted: -99.68 vs. -34.49 pg/ml, p=0.05; adjusted: -101.31 vs -43.19 pg/ml, p=0.08), respectively. Maternal pre-pregnancy BMI correlated with lower child GLP-1 secretion (unadjusted: ρ =-0.30, p=0.21; adjusted: ρ =-0.25, p=0.33) and less ghrelin suppression (unadjusted: ρ =0.55, p=0.01; adjusted: ρ =0.52, p=0.03). Conclusion: These preliminary findings suggest that prenatal exposure to maternal GDM or obesity is associated with altered GLP-1 and ghrelin responses to oral glucose. Further research is needed to elucidate how these changes contribute to metabolic risk in children. Disclosure E.C. Morgan: None. J.M. Alves: None. T. Chow: None. A. Xiang: None. K.A. Page: None. Funding American Diabetes Association (1-14-ACE-36); NIH (RO1DK134079), (RO1DK116858)
期刊介绍:
Diabetes is a scientific journal that publishes original research exploring the physiological and pathophysiological aspects of diabetes mellitus. We encourage submissions of manuscripts pertaining to laboratory, animal, or human research, covering a wide range of topics. Our primary focus is on investigative reports investigating various aspects such as the development and progression of diabetes, along with its associated complications. We also welcome studies delving into normal and pathological pancreatic islet function and intermediary metabolism, as well as exploring the mechanisms of drug and hormone action from a pharmacological perspective. Additionally, we encourage submissions that delve into the biochemical and molecular aspects of both normal and abnormal biological processes.
However, it is important to note that we do not publish studies relating to diabetes education or the application of accepted therapeutic and diagnostic approaches to patients with diabetes mellitus. Our aim is to provide a platform for research that contributes to advancing our understanding of the underlying mechanisms and processes of diabetes.